Illness script · Pediatrics

Bronchiolitis

Viral lower respiratory tract infection causing small airway inflammation and obstruction, predominantly in infants <2 years old.

This illness script for Bronchiolitis covers predisposing factors, classic presentation, mechanism, workup, management, and the clinical pivots that separate it from look-alikes—written for USMLE Step 1 and clerkship reasoning.

Updated Jul 19, 2026All scripts

01

Predisposing factors

  • Most common in infants 2–6 months; peak incidence winter months
  • RSV accounts for ~80% of cases; also hMPV, parainfluenza, rhinovirus
  • Prematurity, chronic lung disease, congenital heart disease → severe disease
  • Daycare attendance, siblings, smoke exposure increase risk
  • Not vaccinated (palivizumab is prophylaxis, not vaccine)

02

Presentation

  • Prodrome: 2–3 days of URI symptoms (rhinorrhea, low-grade fever)
  • Progresses to cough, tachypnea, increased work of breathing
  • Classic exam: diffuse wheezing + crackles in infant <2 years
  • Nasal flaring, intercostal/subcostal retractions, grunting
  • Hypoxia (SpO2 <90%) signals severity; apnea risk in neonates/ex-premies
  • Chest hyperinflation on exam; feeding difficulty common

03

Pathophysiology

  • Viral infection → bronchiolar epithelial necrosis and edema
  • Mucus plugging + inflammatory debris → air trapping and atelectasis
  • Increased airway resistance → wheezing, hyperinflation, V/Q mismatch
  • Infants vulnerable due to small airway diameter and poor collateral ventilation

04

Diagnostics

  • Diagnosis is CLINICAL — no routine labs or imaging required
  • CXR if needed: hyperinflation, peribronchial thickening, patchy atelectasis (can mimic pneumonia)
  • RSV rapid antigen test available but does not change management
  • Pitfall: atelectasis on CXR often misread as pneumonia → avoid unnecessary antibiotics
  • Pulse oximetry guides severity and admission decision

05

Management

  • Supportive care is mainstay: nasal suctioning, hydration, supplemental O2
  • O2 supplementation to maintain SpO2 ≥90–92%
  • High-flow nasal cannula (HFNC) for moderate-severe respiratory distress
  • Admit if SpO2 <90%, apnea, poor feeding, or severe retractions
  • Bronchodilators (albuterol) NOT routinely recommended — no proven benefit
  • Corticosteroids and antibiotics are NOT indicated
  • Palivizumab (anti-RSV monoclonal Ab) for high-risk prophylaxis only

06

Clinical pivots

How to separate this script from the look-alikes that show up on exams and on the wards.

  • Asthma (reactive airway disease)

    Age >2 years, recurrent episodes, family/personal atopy history, responds to bronchodilators

  • Bacterial pneumonia

    High fever, lobar consolidation on CXR, toxic appearance, productive cough — not typical URI prodrome

  • Croup (laryngotracheobronchitis)

    Barky/seal-like cough, stridor (upper airway), no wheezing, older infant/toddler

  • Foreign body aspiration

    Sudden onset without viral prodrome, unilateral wheeze, localized hyperinflation on CXR

View full library

Educational use only. This illness script is a study framework, not medical advice. Confirm decisions with current guidelines and your clinical supervisors.